Showing results (1151-1160 of 4,506) with videos related to
Sort By:
Pageof 451
Advances in Therapy|December 23, 2024
Medicare Advantage Population in the United States: Outcomes of Patients with Asthma Treated with ICS/LABA Before and After Initiation with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI)Alan P Baptist, Guillaume Germain, Jacob Klimek, et al.Advances in Therapy|November 14, 2024
Using Chronic Kidney Disease as a Model Framework to Estimate Healthcare-Related Environmental ImpactJuan Jose Garcia Sanchez, Katherine A Barraclough, Aleix Cases, et al.Advances in Therapy|March 2, 2025
Biologic Treatment Adherence and Persistence in Patients with Palmoplantar Pustulosis: A Real-World, Claims-Based StudySteven R Feldman, Ran Gao, Rhonda L Bohn, et al.Advances in Therapy|February 19, 2025
LymphoTEC: a Retrospective Real-World Study on Lymphocyte Reconstitution After Lymphopenia in Patients with Multiple Sclerosis Treated with Dimethyl Fumarate in FranceJérôme de Sèze, Pierre Labauge, Roland Liblau, et al.Advances in Therapy|November 5, 2024
A Retrospective Claims Analysis of the Rate of Complications in Patients Undergoing Treatment for Paroxysmal Nocturnal HemoglobinuriaDenise Clayton, Jason Shafrin, Glorian P Yen, et al.Advances in Therapy|October 29, 2024
Risk-Benefit Analysis of Novel Treatments for Patients with Generalized Myasthenia GravisA Gordon Smith, Gil I Wolfe, Ali A Habib, et al.Advances in Therapy|November 2, 2024
Dosing Patterns of Dulaglutide and Semaglutide in Patients with Type 2 Diabetes Mellitus in France and Italy: A Retrospective Cohort StudySwarna Khare, Beatrice Osumili, Nele Debackere, et al.Advances in Therapy|November 6, 2025
Therapeutic Adherence in Cardiovascular Diseases: Insights from the Patient and Physician-A Narrative ReviewMaria George, Inese Maurina, Aletta E SchutteAdvances in Therapy|November 1, 2025
Real-World Perspectives on Switching Patients with Multiple Sclerosis from Anti-CD20 Therapy to Cladribine Tablets from USA-Based Advanced Practice Providers: A PodcastChristen F Kutz, Cortnee RomanAdvances in Therapy|November 1, 2025
ADD2Dia: Real-World Clinical Effectiveness of Adding a Sodium-Glucose Cotransporter 2 Inhibitor to Gliclazide-Based Therapy in Type 2 DiabetesRodrigo O Moreira, Nemencio A Nicodemus, Abdurrahman Comlekci, et al.Pageof 451